NEW YORK (GenomeWeb News) — Beckman Coulter today said that third-quarter revenue increased 6.1 percent as profits jumped 31 percent.
 
Total receipts for the three months ended Sept. 30 increased to $631.2 million from $593.4 million year over year.
 
Beckman Coulter attributed the good numbers to increased revenues on consumables, particularly in Europe and, to a lesser extent, in the Far East.
 
R&D costs in the quarter increased 57 percent to $81 million year over year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.